| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |